quofenix
a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin meglumine - community-acquired infections - antibacterials for systemic use, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4.4 and 5.1).consideration should be given to official guidance on the appropriate use of antibacterial agents.
baxdela 300 mg
شركة أدوية الحكمة - hikma pharmaceuticals - delafloxacin 300 mg - 300 mg
baxdela 450 mg/tab
شركة أدوية الحكمة - hikma pharmaceuticals - delafloxacin 450 mg/tab - 450 mg/tab